ENVISION-ENERGY
3.5.2016 10:01:57 CEST | Business Wire | Press release
Envision, one of the world’s leading renewable energy and technology companies, today announced the acquisition of Norway-based BazeField technology in a partnership that will drive both companies forward in the digital energy revolution.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160503005810/en/
The partnership with BazeField is a continuation of Envision’s commitment to cooperate with the best companies around the world to develop solutions to meet global energy and climate challenges, and enable the necessary transition to a low-carbon global economy.
“BazeField is at the cutting edge of renewable energy system management technology,” said Felix Zhang, Envision executive director. “The acquisition will provide the resources and support for BazeField to further develop its state-of-the-art technology, and provide better products and services to its global clients. The synergies and complementary technologies between Envision and BazeField will create a partnership that will drive forward growth and innovation for both companies.”
According to Zhang, the digital energy technology market is at an early stage of development, fragmented and geographically diverse. “At this stage of the market’s development, innovation and growth requires more partnerships and greater cooperation,” he said. “The new relationship between Envision and BazeField will play a key part in achieving those goals and pushing the market forward.”
BazeField will continue to operate independently under the agreement. “The independence of BazeField is important for the success of this partnership,” Zhang said. “With Bazefield operating independently, customers will have more choice and BazeField will have the autonomy it needs to continue its development efforts.”
“We decided we would need a partner to grow with,” said BazeField CEO Sigurd Juvik. “Envision is the right partner for us. The companies have a similar vision for smart energy technology and the partnership offers us the resources and industry insights that will accelerate our product development and entry into new market regions. We have confidence in our technology. Moving forward with Envision Energy is an endorsement of that, and a massive vote of confidence.”
Zhang pointed out that the world is rapidly moving to a future energy system that is completely different from today’s. “This energy future will rely on society and business being able to run an energy system in which digitalisation means greater control and improved efficiency at every juncture,” Zhang said. “Envision Energy and BazeField are at the forefront of this transition, using software to maximise the efficiency of every piece of hardware they help to operate. The global market is undergoing a fundamental paradigm shift and global cooperation is a must.”
After the acquisition is complete, customers will be able to use the same technology platforms they have chosen from Envision or BazeField, but with added innovation and potential. Juvik said, “The combination of BazeField and Envision Energy will accelerate investment in BazeField’s technology, increase both companies’ rate of growth and geographic expansion, and increase employment and investment in Norway and Europe, all of which will help us overcome the challenges we face today in energy and the environment.”
About Envision Energy
Envision Energy (www.envision-energy.com ) is one of the world's largest smart energy management companies and among the eight largest turbine companies in the world with more than 7.5 GW of Envision smart wind turbines in operation. Envision's Energy OS platform is used to manage more than 50 GW of renewable energy assets, including charging stations and energy consumption devices worldwide. Envision has regional offices across Asia, Europe, North and South America and has established global R&D and engineering centers in Denmark, Germany and the United States.
About BazeField
Baze Technology is a software company headquartered in Norway. It’s industry leading product, BazeField Wind, is a turbine independent Wind Farm Management System (WFMS) that provides tools for real-time monitoring, reporting, availability planning, stop and loss analysis and fact-based decision making. BazeField’s Wind Farm Management System includes turnkey interfaces such as: turbine SCADA, grid, met, forecasts, trading systems etc. It also includes a suite of monitoring, analysis and operations management applications, KPI's measurements and reports needed for support in O&M of wind farms.
Envision Energy/BazeField
Transaction Summary
Purpose of the deal
With the partnership with BazeField, Envision Energy continues to cooperate with the best companies around the world to develop solutions to meet the global energy and climate challenges.
Envision Energy
Founded: 2007
HQ: Registered in Hong Kong
Employees: More than 1,000 renewable energy and software development professionals working in 12 countries.
Market position in global renewables energy and technology market:
- Second largest wind turbine company in China
- A top-10 wind turbine technology provider in the world
- Developed a leading lifecycle management system that features smart sensor networks and cloud-based IT infrastructure designed to create smart wind farms
- Largest smart energy management company in the world, currently managing more than 50 million kilowatts of global alternative energy assets
- Largest offshore turbine supplier in China
- Current markets: China, UK, Mexico, Chile, Denmark (R&D), Germany (R&D), US (R&D, System Management)
Products/Services
Wind turbines and systems
Solar power software systems
Smart energy management technology
Many other digital energy solutions
Executives
Zhang Lei - Chief Executive Officer
Felix Zhang - Executive Director
Tim Naylor - Head of Software Sales in Europe
Tim Hertel - Head of Software Sales in North America
John Childs - Head of Turbine Business Development for Europe Middle East & Africa
Michael Friedrich - Chief System Engineer
Mathias Mier - Director of Technology & Quality
Markets
Envision in North America/South America – Aerodynamics R&D, global digital energy centre and innovation lab, Envision Ventures
Envision in Europe – 1 global innovation centres
Envision in APAC – Global manufacturing, R&D, international project CoE business operations and smart energy software R&D
BazeField
Founded: 2007 as a spin-off from CARDIAC AS
HQ: Porsgrunn, Norway
Products/Services
BazeField Wind is a turbine independent Wind Farm Management System (WFMS) that provides tools for real-time monitoring, reporting, availability planning, stop and loss analysis, and fact-based decision-making. Approximately 7 GW of installed wind power capacity are managed on a daily basis.
Executives
Sigurd J. Juvik – Chief Executive Officer
Tor-Egil Tinderholt – Chief Financial Officer/Chief Operating Officer
Thorstein Rinker – Vice President Business Development
John Båserud – Chief Technology Officer
View source version on businesswire.com: http://www.businesswire.com/news/home/20160503005810/en/
Contact:
For Envision Energy:
UK
Stephanie Bailey, +44
(0) 208 618 2809
Press office
Stephanie.bailey@fhflondon.co.uk
or
Norway
Rune
Mørck Wergeland, +47 913 88 914
Press office
rmw@wask.no
or
Brussels
Alexandria
Hicks, +32 470 904 333
Press office
alexandria.hicks@fleishmaneurope.com
or
San
Francisco
Yang Stratton, 650-564-5036
yang.stratton@envision-energy.com
or
Houston
-
Joe Brettell, +1713-513-9511
Press office
joe.brettell@fleishman.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom